Outcomes of a Pharmacy-Driven Inpatient Chronic Obstructive Pulmonary Disease (COPD) Transitions of Care (TOC) Management Process

被引:1
|
作者
Roberts, Aaron [1 ,4 ]
Ball, Meredith Hope [2 ]
Bentley, Austin Clark [1 ]
Rafferty, Aubrie [3 ]
机构
[1] UNC Chapel Hill Eshelman Sch Pharm, Chapel Hill, NC USA
[2] WakeMed Hlth & Hosp, Dept Pharm, Raleigh, NC USA
[3] Mission Hosp, Dept Pharm, Mission Campus, Asheville, NC USA
[4] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, 301 Pharm Ln, Chapel Hill, NC 27599 USA
关键词
transitions of care; COPD; layered learning; READMISSIONS;
D O I
10.1177/08971900231168927
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Current data shows 30% of patients hospitalized for Chronic Obstructive Pulmonary Disease (COPD) exacerbation are readmitted within 30 days. Medication management during transitions of care (TOC) has shown impact on clinical outcomes, however there is insufficient data to suggest how pharmacy TOC services might benefit this patient population. Objective Evaluate the effects of pharmacy-driven COPD TOC services on hospital re-presentation rates. Methods A single-center retrospective chart review conducted of patients hospitalized for a COPD exacerbation. A comprehensive admission-to-discharge TOC service was provided by early immersion pharmacy students, advanced immersion pharmacy students, and an attending pharmacist in a layered learning model. The primary outcome was 30-day re-presentation rate. Secondary outcomes were 90-day re-presentation rate, volume of interventions made and description of the service. Results From 1/1/2019 to 12/31/2019, there were 2422 patients admitted for COPD exacerbation management and 756 patients received at least one intervention from the COPD TOC service. 30% needed a change to inhaler therapy. The provider accepted 57.8% of the recommended changes, and 36% and 33% of eligible patients received an inhaler technique education and bedside delivery of the new inhaler, respectively. Outcomes in the 30-day re-presentation and 90-day censored re-presentation rates for the intervention and control group were 28.5% vs 25.5% (P = .12) and 46.7% vs 42.9%, respectively. Conclusion This study did not find a significant change in 30-day re-presentation rate with a pharmacy-driven COPD TOC service. It did find that a significant number of patients admitted with COPD exacerbation may need an inhaler change, and demonstrates the utility of this kind of TOC service for identifying and correcting medication-related problems unique to this disease state. There were opportunities for improvement in percent of patients receiving the full intended intervention.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 50 条
  • [1] Care transitions service: an inpatient pharmacy-driven medication reconciliation service.
    Togami, John
    Conklin, Jessica
    Ray, Gretchen
    Burnett, Allison
    Dodd, Melanie
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E208 - E209
  • [2] Focussed Inpatient Management Strategies May Improve Clinical Outcomes In Chronic Obstructive Pulmonary Disease (COPD)
    Cushen, B.
    Alsaid, A.
    Cleere, E.
    MacHale, P.
    Tompkins, L.
    Sulaiman, I.
    Mokoka, M. C.
    MacHale, E.
    Costello, R. W.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S398 - S398
  • [3] Focussed Inpatient Management Strategies May Improve Clinical Outcomes In Chronic Obstructive Pulmonary Disease (COPD)
    Cushen, B.
    Alsaid, A.
    Cleere, E.
    MacHale, P.
    Tompkins, L.
    Sulaiman, I.
    Mokoka, M. C.
    MacHale, E.
    Costello, R. W.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S398 - S398
  • [4] INTEGRATED CARE REVIEW OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE INPATIENT MANAGEMENT
    Swami, V
    Smith, T.
    Cho, J.
    Chawla, A.
    Roberts, M.
    Wheatley, J.
    [J]. RESPIROLOGY, 2018, 23 : 22 - 22
  • [5] Improving Transitions of Care in Chronic Obstructive Pulmonary Disease (COPD) Patients presented by
    Alford, Shelleon
    [J]. NURSING RESEARCH, 2021, 70 (03) : E122 - E122
  • [6] Chronic Obstructive Pulmonary Disease: Inpatient Management
    Harte, Brian J.
    Wesorick, David
    Odden, Andrew
    [J]. HOSPITAL MEDICINE CLINICS, 2013, 2 (02) : E169 - E191
  • [7] A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)
    Hellauer, M.
    Hudson, S.
    Johnson, B. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 206 - 206
  • [8] Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Clinic
    Chavez, Pompeyo C.
    Shokar, Navkiran K.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (06) : 446 - 451
  • [9] Chronic Obstructive Pulmonary Disease (COPD) Care Pathway
    Reilly, R.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S465 - S465
  • [10] Inpatient and observation unit costs for chronic obstructive pulmonary disease (COPD)
    O'Brien, JA
    Patrick, AR
    Duran, P
    Caro, JJ
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 525 - 525